NewsRx

Search our medical news database

Leprosy

Indian Vaccine Halves Treatment Time

Published in Vaccine Weekly, April 29th, 1996

A mycobacterial vaccine developed in India cuts leprosy treatment time in half.

According to a report by writer K.S. Jayaraman in the journal Nature Medicine (1996;2(3):262), the vaccine was developed 15 years ago by researchers at the National Institute of Immunology (NII) in New Delhi.

It is comprised of killed Mycobacterium-W, a fast-growing mycobacterium that shares epitopes with Mycobacterium leprae, the etiologic agent of human leprosy.

Current leprosy treatment, as recommended by the World Health Organization, is a combination of dapsone, rifampicin, and clofazimine. This treatment typically takes two to five...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook